While interest rates are set to rise sooner than most predicted, investors should look for a surge from zero to 15% practically overnight. That means investors looking for income will still be reaching for yield and for those looking to score some pretty big dividends, the market may have given you a gift in an esoteric company type.

Many business development companies -or BDCs- are currently traded for discounts to their book values as various funds have sold the firms. That selling wasn’t do to any actual fundamental problem. And given the sector's high yields, now could be a perfect buying opportunity for portfolios still seeking dividends.

Out of Two Major Indexes

The recent selling in BDCs can be attributed to one thing- acquired fund expenses. Business development companies act like publicly traded, mini-private equity firms and as such, they make loans to firms too big for their local bank branch, but too small to launch a corporate bond issue. As middle market lenders, many BDCs will often take equity stakes in the firms and provide managerial assistance in hopes of profiting as these businesses grow.

It’s a profitable place to be and in exchange for various tax benefits, BDCs are required to distribute much of their cash flow back to investors. Unfortunately, it can also be a headache for index and fund providers.

The problem is BDCs are required to report something called acquired fund fees and expenses. While these fees are essentially business expenses- cost of capital etc.- they end up skewing mutual fund and index expense ratios. And in some cases, by a lot. That’s becoming a huge problem as the number of business development companies have surged over the last ten years. Back in 2005, there were just four firms. Today that number sits closer to 30 and the group has over $26 billion in market capitalization.

That increased market cap and size has more BDCs making their way into popular market indexes like the iShares Russell 2000 (NYSE:IWM) and SPDR S&P MidCap 400 (NYSE:MDY). To that end, in order to appease investors who see higher “expense ratios” at the cost of acquired fund fees, index providers S&P and Russell have announced that they will “kick-out” the high yielding securities from their indexes. That’s created plenty of selling pressure over the last few weeks. 

Yet, the growth story for BDCs is still intact. A rising economy is increasing demand for lending, while the IPO and buy-out market remains hot. Both of these factors will continue to see BDCs raising profits and dividends in the months ahead. For investors, the time could be right to snag-up shares as the indexes begin kicking out the firms.

Adding A Dose Of BDC Dividends

Given that selling pressure is not based on real fundamentals and the sector's high yields, investors may want to look at adding some public private equity muscle to a portfolio. A prime way is through the Market Vectors BDC Income ETF (Nasdaq:BIZD).

BIZD tracks 28 different BDCs- including industry titans like Ares Capital (Nasdaq:ARCC) and Prospect Capital (Nasdaq:PSEC), both based in New York. Overall, the ETF offers a broad way to play the sector as well as gain a high dividend yield. BIZD currently spits out a hefty 7.89% distribution. And while at first blush expenses for the fund look high- at 9.34%- the bulk of that is the acquired fees that aren’t actually paid for by investors. Investors can also use the UBS E-TRACS Wells Fargo Business Development Company ETN (Nasdaq:BDCS) to add a wide swath of the sector to their portfolio. 

With biotech and technology being the two hot growth areas, investors may want to focus their BDC efforts in these sectors. To that end, Palo Alto, Calif.-based Hercules Technology Growth Capital (Nasdaq:HTGC) could be the prime pick. HTGC has been immensely successful in identifying the “next-big” things in tech and continues to have many of its portfolio companies IPO. These have included early stakes in Menlo Park, Calif.'s Facebook (NYSE:FB) and San Francisco real-estate firm Trulia (Nasdaq:TRLA). All in all, that’s helped HTGC pay a near 9% dividend. Also providing capital to the high-tech world is Farmington, Conn.-based Horizon Technology Finance (Nasdaq:HRZN). Shares of Horizon currently payout a hefty 11% in dividends. 

Finally, some of the newer and smaller BDCs like Chicago's Golub Capital (Nasdaq:GBDC) and New York's Harvest Capital Credit (Nasdaq:HCAP) could be great buys as they expand their loan portfolios. Meanwhile, investors are treated to larger-than-average sector dividends.

The Bottom Line

The recent selling pressure in the business development company sector has nothing to do with actual fundamentals. For investors looking for high dividends, the recent weakness could be a huge buying opportunity in the BDCs. The previous picks- along with American Capital (Nasdaq:ACAS)- make ideal selections to play the sector and its high yields.


Disclosure - At the time of writing, the author did not own shares of any company mentioned in this article.

Related Articles
  1. Investing

    Pharmaceutical Vs. Biotech Investing: Is It Worth The Risk?

    Investopedia explains: Both pharma and biotech stocks are faced with a costly process that, when successful, can produce extremely profitable products. However, the process is unpredictable.
  2. Markets

    A Primer On The Biotech Sector

    Investing in the biotech sector can involve both huge losses and major gains.
  3. Bonds & Fixed Income

    The Top 5 High Yield Bond Funds for 2016

    Learn about mutual funds and ETFs that invest in high-yield bonds. Read about the risks and rewards associated with investing in high-yield bonds.
  4. Chart Advisor

    Rare Earth Metals Continue To Struggle

    Rare earth metals are used in many of today's products and many investors are wondering if consumer demand is enough to offset the global economic slowdown. We'll take a look at how they are ...
  5. Mutual Funds & ETFs

    3 ETFs to Consider Before an Interest Rate Hike

    Learn about potential impacts of the Federal Reserve boosting interest rates and three ETFs that can help you capitalize on the perceived December increase.
  6. Stock Analysis

    3 of America's Most Expensive Drugs and Who Profits From Them

    Learn about orphan drugs that are some of the most expensive drugs in America. Read about the companies that manufacture these drugs.
  7. Stock Analysis

    The Top 5 Apple Shareholders

    Learn about insiders and institutional investors with large positions in Apple. Read about Carl Icahn's activist campaign against Apple.
  8. Stock Analysis

    If You Had Invested Right After Gilead's IPO

    Find out the present day value of your investment in Gilead Sciences and the amount of shares you would own if you had invested during its IPO.
  9. Mutual Funds & ETFs

    A Complete Guide to Tax Loss Harvesting With ETFs

    Using exchange-traded funds (ETFs) to harvest tax losses can be a smart way to maximize your portfolio's tax efficiency.
  10. Mutual Funds & ETFs

    Why ETFs Are a Smart Investment Choice for Millennials

    Exchange-traded funds offer an investment alternative to cost-conscious millennials who want to diversify their portfolios with less risk.
  1. Should mutual funds be subject to more regulation?

    Mutual funds, when compared to other types of pooled investments such as hedge funds, have very strict regulations. In fact, ... Read Full Answer >>
  2. Do ETFs pay capital gains?

    Exchange-traded funds (ETFs) can generate capital gains that are transferred to shareholders, typically once a year, triggering ... Read Full Answer >>
  3. How do real estate hedge funds work?

    A hedge fund is a type of investment vehicle and business structure that aggregates capital from multiple investors and invests ... Read Full Answer >>
  4. Are Vanguard ETFs commission-free?

    While some Vanguard exchange-traded funds (ETFs) are available commission-free from third-party brokers, a large portion ... Read Full Answer >>
  5. Do Vanguard ETFs require a minimum investment?

    Vanguard completely waives any U.S. dollar minimum amounts to buy its exchange-traded funds (ETFs), and the minimum ETF investment ... Read Full Answer >>
  6. Can mutual fund expense ratios be negative?

    Mutual fund expense ratios cannot be negative. An expense ratio is the sum total of all fees charged by an asset management ... Read Full Answer >>

You May Also Like

Trading Center